As the ICH E6 addendum (R2) becomes a priority for Sponsors to address, some initial Best Practices have become apparent through early innovators and adopters of the guidance. One of the most significant of these is the use of Role-based dashboards to help each level of the Sponsor organization visualize status and performance of Clinical data. With dashboards, they can quickly see and drill into areas such as portfolio and study oversight.
This demo presents a case study of a mid-sized Pharmaceutical company who adopted four role-based dashboards to address their oversight objectives. Some of the capabilities the dashboards provide include:
- Executive view of portfolio status
- VP ClinOps view of performance across studies and CROs
- Study Manager view of site ranking and CRA performance
- CRA view for specific site performance
Details include what drove the Sponsor to a process that included these dashboards and the results they have seen to-date.